CA2575850A1 - Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine - Google Patents

Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine Download PDF

Info

Publication number
CA2575850A1
CA2575850A1 CA002575850A CA2575850A CA2575850A1 CA 2575850 A1 CA2575850 A1 CA 2575850A1 CA 002575850 A CA002575850 A CA 002575850A CA 2575850 A CA2575850 A CA 2575850A CA 2575850 A1 CA2575850 A1 CA 2575850A1
Authority
CA
Canada
Prior art keywords
use according
genistein
surgery
ocular inflammation
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002575850A
Other languages
English (en)
Inventor
Eugene De Juan Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09041931 external-priority patent/US5919813C1/en
Priority claimed from US09/042,440 external-priority patent/US5980929A/en
Application filed by Individual filed Critical Individual
Priority claimed from CA002321560A external-priority patent/CA2321560C/fr
Publication of CA2575850A1 publication Critical patent/CA2575850A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002575850A 1998-03-13 1999-03-12 Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine Abandoned CA2575850A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/041,931 1998-03-13
US09041931 US5919813C1 (en) 1998-03-13 1998-03-13 Use of a protein tyrosine kinase pathway inhibitor in the treatment of diabetic retinopathy
US09/042,440 1998-03-13
US09/042,440 US5980929A (en) 1998-03-13 1998-03-13 Use of a protein tyrosine kinase pathway inhibitor in the treatment of retinal ischmemia or ocular inflammation
CA002321560A CA2321560C (fr) 1998-03-13 1999-03-12 Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002321560A Division CA2321560C (fr) 1998-03-13 1999-03-12 Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine

Publications (1)

Publication Number Publication Date
CA2575850A1 true CA2575850A1 (fr) 1999-09-16

Family

ID=37912385

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002575850A Abandoned CA2575850A1 (fr) 1998-03-13 1999-03-12 Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine

Country Status (1)

Country Link
CA (1) CA2575850A1 (fr)

Similar Documents

Publication Publication Date Title
CA2321560C (fr) Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine
US5919813A (en) Use of a protein tyrosine kinase pathway inhibitor in the treatment of diabetic retinopathy
US6028099A (en) Use of an inhibitor of the protein tyrosine kinase pathway in the treatment of choroidal neovascularization
US6399655B1 (en) Method for the prophylactic treatment of cataracts
US5980929A (en) Use of a protein tyrosine kinase pathway inhibitor in the treatment of retinal ischmemia or ocular inflammation
KR20060127043A (ko) 녹내장성 망막병증 및 시각신경병증의 치료용 약제
US6500813B1 (en) Ophthalmic composition containing active vitamin D
KR20030068150A (ko) 개선된 치료 방법
JP2010215667A (ja) 外網膜の疾患を処置する薬剤を製造するためのβ−アドレナリン作用受容体アンタゴニストの使用
US20110020448A1 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
Colitz et al. Cetacean and pinniped ophthalmology
KR100698449B1 (ko) 안구 혈관신생 질환 치료용 스타우로스포린 유도체의 용도
Okka et al. Effects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys
JP4920134B2 (ja) 眼障害の処置におけるプロテインチロシンキナーゼ経路インヒビターの使用
Rajesh et al. Panuveitis as a presenting feature of giant cell arteritis
CA2575850A1 (fr) Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine
SCHLOTE et al. Pupillary distortion after contact transscleral diode laser cyclophotocoagulation
MXPA00008988A (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
KR101327663B1 (ko) 안지오제닌의 신규 용도
Catoira-Boyle et al. Medical Management of Glaucoma
DANIEL et al. Isolated focal melanocytes collection in the lacrimal sac
DANIEL et al. http://bjo. bmj. com
HK1040182B (en) Use of staurosporine derivatives for treating ocular neovascular diseases

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead